AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2017
Sep 22, 2017
35599_dirs_2017-09-21_26198391-015a-4b98-b5d3-112009452dbe.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2017-09-11
Reporting Person: Islam Khalid (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.31 | 2021-04-25 | Common shares (133333) | Direct | |
| Stock Option (right to buy) | $2.69 | 2021-12-31 | Common shares (10000) | Direct | |
| Stock Option (right to buy) | $1.13 | 2022-12-11 | Common shares (50000) | Direct | |
| Stock Option (right to buy) | $2.44 | 2023-06-09 | Common shares (20492) | Direct | |
| Stock Option (right to buy) | $5.10 | 2024-06-27 | Common shares (25000) | Direct |
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20